🔗 Permalink

Inventor profile of:

Stuart A. LIPTON

City:

Rancho Santa Fe, California

Country:

United States

Published Applications:

Last publication date:

2023-11-02

Top Assignees for applications by Stuart A. LIPTON

The entities that hold a legal rights for patent applications filed by inventor LIPTON Stuart A.:

Sanford-Burnham Medical Research Institute 5 La Jolla, CA United States
Burnham Institute for Medical Research 3 La Jolla, CA United States
Adamas Pharmaceuticals, Inc. 2 Emeryville, CA United States
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2 Boston, MA United States
YALE UNIVERSITY 2 New Haven, CT United States
BRIGHAM AND WOMEN'S HOSPITAL, INC. 1 Boston, MA United States

Recent patent applications by LIPTON Stuart A.

Stuart A. LIPTON from Rancho Santa Fe, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-02

US20230346713A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS

#2 | 2020-11-26

US20200368177A1

Human necessities

Methods and compositions for treating neurological conditions

#3 | 2011-12-01

US20110293556A1

Human necessities

TREATMENT OF INSULIN RESISTANCE/METABOLIC SYNDROME TO ALLEVIATE THE RISKS OF DEMENTIA

#4 | 2011-09-01

US20110212070A1

Physics

Methods of differentiating and protecting cells by modulating the p38/MEF2 pathway

#5 | 2011-04-05

US9876187

Methods of differentiating and protecting cells by modulating the P38/MEF2 pathway

#6 | 2011-02-24

US20110045098A1

Chemistry; metallurgy

Excitatory glycine receptors and methods

#7 | 2010-09-07

US10222772

Excitatory glycine receptors and methods

#8 | 2010-06-03

US20100137448A1

Human necessities

Methods for Treating Neuropsychiatric Disorders with NMDA Receptor Antagonists

#9 | 2009-09-17

US20090234021A1

Human necessities

Treatment of Demyelinating Conditions

#10 | 2009-04-09

US20090093409A1

Human necessities

NEUROPROTECTIVE SYNERGY OF ERYTHROPOIETIN AND INSULIN-LIKE GROWTH FACTORS

#11 | 2009-04-02

US20090088367A1

Human necessities

Treatment of Insulin Resistance/Metabolic Syndrome to Alleviate the Risks of Dementia

#12 | 2008-07-31

US20080183003A1

Chemistry; metallurgy

AMINOADAMANTANE DERIVATIVES AS THERAPEUTIC AGENTS

#13 | 2006-05-18

US20060106222A1

Chemistry; metallurgy

Aminoadamantane derivatives as therapeutic agents

#14 | 2005-09-08

US20050197284A9

Human necessities

Neuroprotective synergy of erythropoietin and insulin-like growth factors

#15 | 2005-06-09

US20050124701A1

Human necessities

Method of targeting a therapeutic agent

#16 | 2005-03-24

US20050065219A1

Human necessities

Treatment of demyelinating conditions

#17 | 2005-01-06

US20050004022A1

Human necessities

Pharmaceutical compositions for treating painful neuropathy and methods of treating same

InventorID:

2914583 ⎘